Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Frequent Mutation of the Polycomb-Associated Gene ASXL1 In Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

Marta Fernandez-Mercado, Andrea Pellagatti, Janet Perry, Cristina Fernandez-Santamaria, Maria J. Calasanz, Maria J. Larrayoz, Maria D. Odero, Sally Killick, James S. Wainscoat, Jacqueline Boultwood

Blood (2010) 116 (21): 2940.

https://doi.org/10.1182/blood.V116.21.2940.2940

Published: 2010

Journal Articles

SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemia

Ion Cristóbal, Francisco J. Blanco, Laura Garcia-Orti, Nerea Marcotegui, Carmen Vicente, José Rifon, Francisco J. Novo, Eva Bandres, María J. Calasanz, Carmelo Bernabeu, María D. Odero

Blood (2010) 115 (3): 615–625.

https://doi.org/10.1182/blood-2009-06-227363

Published: 2010

Includes: Supplemental data

Journal Articles

MYB Overexpression Is Directly Involved in Acute Myeloid Leukemia Pathogenesis and Could Constitute a New Therapeutic Target for Patients with Aberrant Expression of This Gene.

Carmen Vicente, Ph.D., Ana Conchillo, Ph.D., Daphnie Pauwels, BSc, Iria Vazquez, Ph.D., Laura Garcia-Orti, BSc, Maria J. Calasanz, Ph.D., Idoya Lahortiga, Ph.D., Jan Cools, Ph.D., Maria D. Odero, MD, Ph.D.

Blood (2009) 114 (22): 2402.

https://doi.org/10.1182/blood.V114.22.2402.2402

Published: 2009

Journal Articles

Epigenomic Analysis of Acute Myeloid Leukemia Identifies Specific Patterns and Markes with Clinical and Biological Relevance.

Sara Alvarez, MD, PhD, Javier Suela, PhD, Ana Valencia, MD, Agustin Fernandez, PhD, Mark Wunderlich, MS, Xabier Agirre, PhD, Felipe Prosper, MD, Jose Ignacio Martin-Subero, PhD, Alba Maiques, MSc, Francesco Acquadro, MSc, Sandra Rodriguez-Perales, PhD, Maria J. Calasanz, PhD, Jose Roman-Gomez, MD, Reiner Siebert, MD, PhD, James C. Mulloy, PhD, José Cervera, MD, PhD, Miguel A. Sanz, MD, PhD, Manel Esteller, MD, PhD, Juan C Cigudosa, PhD

Blood (2009) 114 (22): 2394.

https://doi.org/10.1182/blood.V114.22.2394.2394

Published: 2009

Journal Articles

Prevalence of EVI1 Overexpression and Its Impact on Diagnosis and Prognosis in Acute Myeloid Leukemia: A Study of 490 Patients from the Spanish Group of Myeloid Malignancies of the RTICC.

Iria Vazquez, BSc, José Cervera, MD, PhD, Maria Gomez-Benito, Ph.D., Nerea Marcotegui, BSc, Miren Maicas, BSc, Ana Conchillo, Ph.D., Ana Valencia, Ph.D., Eva Lumbreras, Ph.D., Salut Brunet, MD, Maria T. Gómez-Casares, MD, Ph.D., Jesus-Maria Hernandez-Rivas, MD, Ph.D., Maria J. Calasanz, PhD, Jorge Sierra, MD, PhD, Maria D. Odero, MD, PhD

Blood (2008) 112 (11): 1515.

https://doi.org/10.1182/blood.V112.11.1515.1515

Published: 2008

Journal Articles

Risk-adapted treatment of acute promyelocytic leukemia with all- trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group

Blood (2008) 112 (8): 3130–3134.

https://doi.org/10.1182/blood-2008-05-159632

Published: 2008

Journal Articles

A Gain of Function Mutation in JAK2 Is Frequently Found in Patients with AML-M2 and Normal Karyotype.

Nerea Marcotegui, BSc, Idoya Lahortiga, PhD, Iria Vazquez, BSc, Jose L. Vizmanos, PhD, Ion Cristobal, BSc, Cristina Ormazabal, BSc, Eva Bandres, PhD, Maria J. Larrayoz, BSc, Carmen Vicente, BSc, Maria J. Calasanz, PhD, María D. Odero, MD, PhD

Blood (2005) 106 (11): 2366.

https://doi.org/10.1182/blood.V106.11.2366.2366

Published: 2005

Journal Articles

GATA2 Is Overexpressed in 46% of Patients with AML and Normal Karyotype. The Mutational Pattern FLT3-ITD/GATA2/WT1 Could Define a Group of Patients with Normal Karyotype and AML-M1 Subtype.

Idoya Lahortiga, PhD, Iria Vazquez, BSc, Nerea Marcotegui, BSc, Eva Bandres, PhD, Raquel Malumbres, PhD, Maria J. Larrayoz, BSc, Carmen Vicente, BSc, Jose Cervera, MD, PhD, Jesus M. Hernandez, MD, PhD, Jesus Garcia-Foncillas, MD, PhD, Maria T. Ardanaz, MD, Filomena Floristan, MD, Maria J. Calasanz, PhD, Maria D. Odero, MD, PhD

Blood (2005) 106 (11): 2378.

https://doi.org/10.1182/blood.V106.11.2378.2378

Published: 2005

Journal Articles

CML and Imatinib Mesylate: Response Related to Karyotype.

Araceli Rubio-Martinez, MD, PhD, Valle Recasens, MD, Maria D. Odero, MDPhD, Daniel Rubio-Felix, MDPhD, Maria J. Calasanz, MDPhD, Pilar Mayayo, MD, Manuel Giralt, MDPhD, Pilar Giraldo, MDPhD

Blood (2005) 106 (11): 4866.

https://doi.org/10.1182/blood.V106.11.4866.4866

Published: 2005

Journal Articles

Genetic Aberrations and Response to Fludarabine as First Line Treatment in a Serie of B-CLL Patients.

Pilar Giraldo, MD, PhD, Araceli Rubio-Martinez, MDPhD, Valle Recasens, MD, Mikel Valganon, MD, Paz Latre, MD, Daniel Rubio-Felix, MDPhD, Maria J. Calasanz, MDPhD, Maria D. Odero, MDPhD

Blood (2005) 106 (11): 2131.

https://doi.org/10.1182/blood.V106.11.2131.2131

Published: 2005

Journal Articles

Additional Chromosome Abnormalities Have No Prognostic Value in Acute Promyelocytic Leukemia Patients Treated with Simultaneous ATRA and Anthracycline-Based Chemotherapy: An Update of the APL96 and APL99 Pethema Protocols.

Blood (2004) 104 (11): 2019.

https://doi.org/10.1182/blood.V104.11.2019.2019

Published: 2004

Journal Articles

Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia

Jose Roman-Gomez, Antonio Jimenez-Velasco, Juan A. Castillejo, Xabier Agirre, Manuel Barrios, German Navarro, Francisco J. Molina, Maria J. Calasanz, Felipe Prosper, Anabel Heiniger, Antonio Torres

Blood (2004) 104 (8): 2492–2498.

https://doi.org/10.1182/blood-2004-03-0954

Published: 2004

NARROW

Frequent Mutation of the Polycomb-Associated Gene ASXL1 In Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemia

MYB Overexpression Is Directly Involved in Acute Myeloid Leukemia Pathogenesis and Could Constitute a New Therapeutic Target for Patients with Aberrant Expression of This Gene.

Epigenomic Analysis of Acute Myeloid Leukemia Identifies Specific Patterns and Markes with Clinical and Biological Relevance.

Prevalence of EVI1 Overexpression and Its Impact on Diagnosis and Prognosis in Acute Myeloid Leukemia: A Study of 490 Patients from the Spanish Group of Myeloid Malignancies of the RTICC.

Risk-adapted treatment of acute promyelocytic leukemia with all- trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group

A Gain of Function Mutation in JAK2 Is Frequently Found in Patients with AML-M2 and Normal Karyotype.

GATA2 Is Overexpressed in 46% of Patients with AML and Normal Karyotype. The Mutational Pattern FLT3-ITD/GATA2/WT1 Could Define a Group of Patients with Normal Karyotype and AML-M1 Subtype.

CML and Imatinib Mesylate: Response Related to Karyotype.

Genetic Aberrations and Response to Fludarabine as First Line Treatment in a Serie of B-CLL Patients.

Additional Chromosome Abnormalities Have No Prognostic Value in Acute Promyelocytic Leukemia Patients Treated with Simultaneous ATRA and Anthracycline-Based Chemotherapy: An Update of the APL96 and APL99 Pethema Protocols.

Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only